搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
ThePrint
11 小时
LUX Hospitals Introduces ENDOANAL Real-Time Ultrasound-Guided Laser Procedure for Fistula ...
Lux Hospitals, Hyderabad, proudly announces the launch of the ENDOANAL Real-Time Ultrasound-Guided Laser Procedure for ...
verywellhealth
1 天
8 Best Teas to Drink When You Have a Cold, According to Experts
There are many teas you can drink when you have a cold, but the best options help alleviate your symptoms. Here are some top ...
Daily
3 天
GSK Nucala approved in China for treatment of adults with chronic rhinosinusitis with nasal ...
London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...
Pharmabiz
3 天
GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis ...
GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...
4 天
GSK's Sinus Disease Drug Secures Approval In China
On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...
4 天
GSK’s Nucala approved in China as add-on therapy for adults with CRSwNP
GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that targets ...
newsmeter
4 天
Hyderabad: How doctors at DDRCC performed rare Maxillary Sinus Carcinoma surgery
Rare cancer of the face where the person suffered from facial swelling, a large lump of 10 cm on the right jaw, watery eyes, ...
5 天
'Critical incident' is declared at Surrey hospital as patients are sent home
A Surrey hospital has been placed in a 'critical' situation. Due to high levels of demand and winter viruses, Surrey and ...
PharmiWeb
5 天
ENT Treatment Market Projected to Reach USD 33,520 Million by 2030, Growing at a CAGR of 5.2%
IntroductionThe demand for ENT (Ears, Nose, and Throat) treatment solutions is rising significantly due to the increasing ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈